HOME > VC DEALS > Octave Bioscience
Deal IconDeal

Octave Bioscience

Octave Bioscience raises $35.6M Series C

Octave Bioscience, a Menlo Park, CA-based precision care management platform for neurological conditions, raised $35.6 million in a Series C fundraising round led by Byers Capital, Blue Venture Fund, and Northpond Ventures.

More on VC News Daily →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs